Evidence map›Paper›PMID 34686127›Full record

ArticleBMC bioinformatics2021

ILRC: a hybrid biomarker discovery algorithm based on improved L1 regularization and clustering in microarray data.

Kun Yu, Weidong Xie, Linjie Wang, Wei Li

Abstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. The Prognostic Value and Immune Landscapes of a mFrontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kun Yu *College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Weidong Xie *School of Computer Science and Engineering, Northeastern University, Shenyang, China.
Linjie WangSchool of Computer Science and Engineering, Northeastern University, Shenyang, China.
Wei LiKey Laboratory of Intelligent Computing in Medical Image (MIIC), Northeastern University, Ministry of Education, Shenyang, China. liwei@cse.neu.edu.cn.

Funding

Engineering Technology Research Center 17-134-8-00Fundamental Research Funds for the Central Universities N2016006National Natural Science Foundation of China No. U1708261
6 · The paper itself

Abstract

backgroundFinding significant genes or proteins from gene chip data for disease diagnosis and drug development is an important task. However, the challenge comes from the curse of the data dimension. It is of great significance to use machine learning methods to find important features from the data and build an accurate classification model.

resultsThe proposed method has proved superior to the published advanced hybrid feature selection method and traditional feature selection method on different public microarray data sets. In addition, the biomarkers selected using our method show a match to those provided by the cooperative hospital in a set of clinical cleft lip and palate data.

methodIn this paper, a feature selection algorithm ILRC based on clustering and improved L1 regularization is proposed. The features are firstly clustered, and the redundant features in the sub-clusters are deleted. Then all the remaining features are iteratively evaluated using ILR. The final result is given according to the cumulative weight reordering.

conclusionThe proposed method can effectively remove redundant features. The algorithm's output has high stability and classification accuracy, which can potentially select potential biomarkers.

Indexed as

Cleft LipCleft PalateAlgorithmsCluster AnalysisHumansOligonucleotide Array Sequence AnalysisBiomarkerFeature selectionMachine learningMicroarray

Identifiers

PMID34686127
PMCPMC8532312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.